VALIDATION DATA

MEASUREMENT PROPERTIES
Limitations English only
Observations

No translation needed.

1. RELIABILITY
A. Internal Consistency Tested
Cronbach's (Describe)

Cronbach’s alpha for the CDAI was 0.833

B. Reliability intraobserver or test-retest Tested
Continuous scores: intraclass
correlation coefficient (ICC)
Dichotomus: Cohen kappa (Describe)

When repeated testing 1 week apart was performed, ICC values were 0.89 for the CDAI.

C. Reliability interobserver or Measurement error Not Tested
Standard error of measurement (SEM),
smallest detectable change (SDC) or
Limits of agreement (LoA) (Describe)
2. VALIDITY
A. Content validity: face validity Tested
Expert opinion (relevance and
comprehensiveness) (Describe)

The CDAI includes variables from the ACR core set of measures used to assess outcomes in RA. No measures of disability or joint damage are included. 

B. Construct Validity:
Structural validity
Tested
Hypotheses-testing Tested
Cross-cultural validity Tested
Brief Description

The contribution of CRP in the SDAI was shown to be low (about 5%) and thus authors excluded CRP from the SDAI, developing the CDAI. Pearson correlation analysis between SDAI and CDAI in an inception cohort (n = 91 patients) and in a cross-sectional routine cohort correlated almost perfectly.

C. Criterion validity Tested
Comparison with a 'gold standard' Continuous scores:
correlations, ROC curves Dichotomus:
Sensitivity & Specificity (Describe)

Gold standard was DAS28. Linear regression analysis showed a significant correlation between DAS28 and CDAI (R2 =0.873; p<0.0001).

The ROC curves to discriminate between patients categorized by each criteria of disease activity, i.e. remission and/or low disease activity criteria and by moderate and/or high disease activity criteria in the 2 models with the DAS28 and CDAI indices were similar. The discriminatory power of both indices was good, without significant difference, with an AUC of 0.904 (95% CI 0.893±0.915) for DAS28, and 0.899 (95% CI 0.877±0.901) for CDAI.